The global healthcare technology (HealthTech) and medical technology (MedTech) mergers and acquisitions ecosystem in August 2026 operates under a regime defined by institutional market participants as "HealthTech 2.0" or "Industrial Maturity". Moving past the venture subsidised capital deployment of the post-pandemic era and the severe valuation compression experienced during 2022–2023, current market mechanics demonstrate disciplined capital allocation, rigorous underwriting

Average HealthTech deal size has more than tripled since 2022, but the entry multiples that make a fund's vintage are still found below €250M EV. Global and European healthcare M&A surged in 2025, with global transaction value reaching $546.7 billion, a 38% increase year-over-year. In Europe, private equity healthcare buyout value reached $80.9 billion in 2025 and is projected to surpass $95.0 billion in 2026. Disclosed global healthcare buyout value exceeded $191 billion in

The Strategic Evolution of Global Health Systems into Clinical Data Foundries: A 2030 Roadmap for Data Assetisation and Modular AI Architecture. The global healthcare landscape is currently traversing a foundational shift that redefines the essence of the clinical record. Historically, health systems viewed patient documentation as a necessary but cumbersome administrative burden, a repository of past events required primarily for billing, legal compliance and basic clinical

The European healthcare technology (HealthTech) mergers and acquisitions (M&A) market is navigating a period of cautious yet discernible rebound in 2025. This resurgence is primarily propelled by improving macroeconomic conditions, substantial private equity dry powder and a pervasive strategic imperative for digital transformation across the healthcare ecosystem.